Related references
Note: Only part of the references are listed.Metabolic rewiring in mutant Kras lung cancer
Emma M. Kerr et al.
FEBS JOURNAL (2018)
Targeting metabolic reprogramming in KRAS-driven cancers
Kenji Kawada et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer
Jiqin Zhang et al.
MOLECULAR CANCER (2017)
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
Jiyeon Kim et al.
NATURE (2017)
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Arvin M. Gouw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Metabolic Interactions in the Tumor Microenvironment
Costas A. Lyssiotis et al.
TRENDS IN CELL BIOLOGY (2017)
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer
Milica Momcilovic et al.
CELL REPORTS (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
One-carbon metabolism in cancer
Alice C. Newman et al.
BRITISH JOURNAL OF CANCER (2017)
LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells
Y. M. Whang et al.
ONCOGENE (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
RAS isoforms and mutations in cancer at a glance
G. Aaron Hobbs et al.
JOURNAL OF CELL SCIENCE (2016)
Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models
Robert U. Svensson et al.
NATURE MEDICINE (2016)
Clinical Implications of Genomic Discoveries in Lung Cancer
Charles Swanton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
Jared R. Mayers et al.
SCIENCE (2016)
Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo
Laura Brunelli et al.
SCIENTIFIC REPORTS (2016)
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
Johanna Mondesir et al.
JOURNAL OF BLOOD MEDICINE (2016)
KRAS oncogene in lung cancer: focus on molecularly driven clinical trials
Emmanuelle Kempf et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Oncogene-Directed Alterations in Cancer Cell Metabolism
Arvindhan Nagarajan et al.
TRENDS IN CANCER (2016)
Resisting Resistance: Targeted Therapies in Lung Cancer
Jessica J. Lin et al.
TRENDS IN CANCER (2016)
Glucose metabolism provide distinct prosurvival benefits to non-small cell lung carcinomas
Rongrong Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases
Stephane Renaud et al.
BRITISH JOURNAL OF CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Regulation of Glutamine Carrier Proteins by RNF5 Determines Breast Cancer Response to ER Stress-Inducing Chemotherapies
Young Joo Jeon et al.
CANCER CELL (2015)
Metabolic Dependencies in RAS-Driven Cancers
Alec C. Kimmelman
CLINICAL CANCER RESEARCH (2015)
Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A Paradigm for Precision Cancer Medicine
Ryohei Katayama et al.
CLINICAL CANCER RESEARCH (2015)
Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
Mohamed Hassanein et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation
Katherine Sellers et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer
Gorjan Hrustanovic et al.
NATURE MEDICINE (2015)
Metabolic consequences of oncogenic IDH mutations
Seth J. Parker et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survival
Wout Megchelenbrink et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Amino acid management in cancer
Zhi-Yang Tsun et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Targeting AMPK for cancer prevention and treatment
Weidong Li et al.
ONCOTARGET (2015)
Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines
Britta Stolze et al.
SCIENTIFIC REPORTS (2015)
Teaching the fundamentals of electron transfer reactions in mitochondria and the production and detection of reactive oxygen species
Ryan J. Mailloux
REDOX BIOLOGY (2015)
Non-small-cell lung cancer
Cesare Gridelli et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Glycine Decarboxylase Is an Unusual Amino Acid Decarboxylase Involved in Tumorigenesis
Maybelle Kho Go et al.
BIOCHEMISTRY (2014)
Regulation of pyruvate metabolism and human disease
Lawrence R. Gray et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Epidermal Growth Factor Receptor ( EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
Hideki Makinoshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
c-Myc Programs Fatty Acid Metabolism and Dictates Acetyl-CoA Abundance and Fate
Lia R. Edmunds et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Quantitative Proteomic Approach to Understand Metabolic Adaptation in Non-Small Cell Lung Cancer
Alfonso Martin-Bernabe et al.
JOURNAL OF PROTEOME RESEARCH (2014)
KRAS Mutation Status Is Associated with Enhanced Dependency on Folate Metabolism Pathways in Non-Small Cell Lung Cancer Cells
Diarmuid M. Moran et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Ji Zhang et al.
MOLECULAR CELL (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Regulation of mTORC1 by amino acids
Liron Bar-Peled et al.
TRENDS IN CELL BIOLOGY (2014)
Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
Laura Brunelli et al.
ONCOTARGET (2014)
Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
Yimin Zhang et al.
ONCOTARGET (2014)
Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)
S. Dearden et al.
ANNALS OF ONCOLOGY (2013)
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
Y. Storozhuk et al.
BRITISH JOURNAL OF CANCER (2013)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
Rizwan Haq et al.
CANCER CELL (2013)
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
Thomas Yau et al.
INVESTIGATIONAL NEW DRUGS (2013)
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
Patrick A. Ott et al.
INVESTIGATIONAL NEW DRUGS (2013)
KRAS Mutation: Should We Test for It, and Does It Matter?
Patrick J. Roberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Metabolic Alterations in Lung Cancer-Associated Fibroblasts Correlated with Increased Glycolytic Metabolism of the Tumor
Virendra K. Chaudhri et al.
MOLECULAR CANCER RESEARCH (2013)
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
Hongyoon Choi et al.
LUNG CANCER (2013)
Genetic alterations defining NSCLC subtypes and their therapeutic implications
Larissa A. Pikor et al.
LUNG CANCER (2013)
Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
Daquan Meng et al.
LUNG CANCER (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Metabolic targets for cancer therapy
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
Tomoko Saito et al.
PLOS ONE (2013)
Cancer metabolism: fatty acid oxidation in the limelight
Arkaitz Carracedo et al.
NATURE REVIEWS CANCER (2013)
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang et al.
CELL (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Mariia O. Yuneva et al.
CELL METABOLISM (2012)
Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
Jaime Acquaviva et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC
Wei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer
M. C. Garassino et al.
ANNALS OF ONCOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ Visualizing the therapeutic effects of metformin in tumor tissue
Diana Whitaker-Menezes et al.
CELL CYCLE (2011)
Comparative Metabolic Flux Profiling of Melanoma Cell Lines BEYOND THE WARBURG EFFECT
David A. Scott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse: A Children's Oncology Group Study (POG 8866)
Joanne Kurtzberg et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato et al.
NATURE (2011)
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Jason W. Locasale et al.
NATURE GENETICS (2011)
Rapamycin passes the torch: a new generation of mTOR inhibitors
Don Benjamin et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells
Alessandra Baracca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
T-S Yang et al.
BRITISH JOURNAL OF CANCER (2010)
Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
Evan S. Glazer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies
Chen Mao et al.
LUNG CANCER (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
IDH mutations in glioma and acute myeloid leukemia
Lenny Dang et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition
C. L. Mahoney et al.
BRITISH JOURNAL OF CANCER (2009)
Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)
Teresa W. M. Fan et al.
MOLECULAR CANCER (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
mtDNA depletion confers specific gene expression profiles in human cells grown in culture and in xenograft
Darren Magda et al.
BMC GENOMICS (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
ATP Citrate Lyase: Activation and Therapeutic Implications in Non-Small Cell Lung Cancer
Toshiro Migita et al.
CANCER RESEARCH (2008)
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells
Sudha Mannava et al.
CELL CYCLE (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Chemical inhibition of Acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells
Annelies Beckers et al.
CANCER RESEARCH (2007)
LKB1 modulates lung cancer differentiation and metastasis
Hongbin Ji et al.
NATURE (2007)
Forum original research communication
Thomas K. Hunt et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
PEG-asparaginase
Cecilia H. Fu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Regulation of tumor pH and the role of carbonic anhydrase 9
Pawel Swietach et al.
CANCER AND METASTASIS REVIEWS (2007)
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Karin Fischer et al.
BLOOD (2007)
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer
J. Carretero et al.
ONCOGENE (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Succinate dehydrogenase and fumarate hydratase:: linking mitochondrial dysfunction and cancer
A. King et al.
ONCOGENE (2006)
Ras-dependent carbon metabolism and transformation in mouse broblasts
F. Chiaradonna et al.
ONCOGENE (2006)
Mitochondrial transfer between cells can rescue aerobic respiration
JL Spees et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
NMS Al-Saffar et al.
CANCER RESEARCH (2006)
ATP citrate lyase inhibition can suppress tumor cell growth
G Hatzivassiliou et al.
CANCER CELL (2005)
Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells
HQ Wang et al.
ONCOGENE (2005)
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions
W Pao et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MTOR-targeted therapy of cancer with rapamycin derivatives
S Vignot et al.
ANNALS OF ONCOLOGY (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies
F Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A phase I-II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma
NR Agrawal et al.
CANCER (2003)
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers
A Ramírez de Molina et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors
CW Taylor et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Share Paper
